Post-ERCP Acute Pancreatitis
Conditions
Brief summary
The purpose of this study is to compare the incidence of post-ERCP pancreatitis (PEP) in chronic pancreatitis (CP) patients to that in biliary disease patients, to determine whether CP patients in early clinical stage have a higher PEP incidence, and to identify the predictive and protective factors for PEP in chronic pancreatitis patients.
Detailed description
Analysis of patients with chronic pancreatitis (CP group) and biliary disease (BD group) in Changhai Hospital from January 2011 to May 2015 were conducted. Difference of PEP incidences between BD group and CP group, as well as between M-ANNHEIM subcategories were calculated by chi-square test or Fisher's exact test. The predictive and protective factors for PEP were investigated by univariate and multivariate analysis.
Interventions
OTHERchronic pancreatitis
patients with chronic pancreatitis
Sponsors
Changhai Hospital
Study design
Observational model
CASE_CONTROL
Eligibility
Sex/Gender
ALL
Age
5 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* patients with an endoscope inserted to cannulate the pancreatic/biliary duct were included.
Exclusion criteria
* patients in whom the papilla of Vater was not reached; * patients who underwent stent removal procedures without ductal cannulation; * patients in whom the intubation was failed.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numbers of chronic pancreatitis patients with post-ERCP pancreatitis, diabetes mellitus, steatorrhea, previous pancreatitis, previous PEP, pancreatic divisum, jaundice, ESWL, pancreatic duct stone, drainage and minor papilla pancreatogram. | 8 months |
Secondary
| Measure | Time frame |
|---|---|
| Numbers of biliary disease patients with post-ERCP pancreatitis, previous pancreatitis and previous PEP. | 2 months |
Outcome results
None listed